ACB - Aurora Cannabis Inc


4.81
0.100   2.079%

Share volume: 1,981,404
Last Updated: 04-25-2025
Pharmaceutical Products/Medicinal Chemicals: -0.07%

PREVIOUS CLOSE
CHG
CHG%

$4.71
0.10
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
19%
Profitability 0%
Dept financing 25%
Liquidity 0%
Performance 40%
Performance
5 Days
12.91%
1 Month
4.11%
3 Months
-13.10%
6 Months
-13.10%
1 Year
-13.10%
2 Year
-13.10%
Key data
Stock price
$4.81
P/E Ratio 
N/A
DAY RANGE
$4.75 - $5.00
EPS 
N/A
52 WEEK RANGE
$3.75 - $5.58
52 WEEK CHANGE
-$13.10
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
06-20-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$1,227,819
AVERAGE 30 VOLUME 
$1,020,159
Company detail
CEO: Miguel Martin
Region: US
Website: auroramj.com
Employees: 1,340
IPO year: 2018
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; herb mills for using CanniMed herbal cannabis products.

Recent news
loading